...
机译:肉毒蛋白与抗凝抗凝对脑静脉血栓形成的疗效和安全性
Departments of Neurology and Neurosurgery Xuanwu Hospital Capital Medical University;
Departments of Neurology and Neurosurgery Xuanwu Hospital Capital Medical University;
Departments of Neurology and Neurosurgery Xuanwu Hospital Capital Medical University;
Department of Neurosurgery Wayne State University School of Medicine;
Departments of Neurology and Neurosurgery Xuanwu Hospital Capital Medical University;
Departments of Neurology and Neurosurgery Xuanwu Hospital Capital Medical University;
Departments of Neurology and Neurosurgery Xuanwu Hospital Capital Medical University;
Departments of Neurology and Neurosurgery Xuanwu Hospital Capital Medical University;
Center of Stroke Beijing Institute for Brain Disorders;
Departments of Neurology and Neurosurgery Xuanwu Hospital Capital Medical University;
Departments of Neurology and Neurosurgery Xuanwu Hospital Capital Medical University;
Cerebral venous thrombosis; Batroxobin; Anticoagulation; Fibrinogen; Recanalization;
机译:肉毒蛋白与抗凝抗凝对脑静脉血栓形成的疗效和安全性
机译:巴曲酶联合抗凝治疗可促进脑静脉血栓形成中的静脉窦再通:真实经验
机译:使用大型孔中间吸毒导管的安全性和功效,或组合治疗急性脑静脉窦血栓形成:多中心经验
机译:评估一种用于静脉再通的新型非侵入性超声设备:在近期静脉血栓形成的体外模型中,在2.25 MHz处评估血栓形成的可行性和安全性
机译:当前抗凝治疗的成本效果与长期华法林抗凝治疗之前的CYP2C9和VKORC1遗传检测的关系:基于静脉血栓栓塞自然史的离散事件模拟模型的实现。
机译:巴曲酶联合抗凝治疗可能会促进脑静脉血栓形成中的静脉窦再通:真实经验
机译:Batroxobin与抗凝血相结合可以促进脑静脉血栓形成的静脉窦重新化:真实世界的经历
机译:特发性静脉血栓栓塞后抗凝和结果的差异有限持续时间:meta分析